Cartilage Repair/Regeneration Market Growth, Size, Share, Trends, and Forecast 2032

Table Of Content

Methodology

Free Analysis

Smooth lining which acts as a joint lubricant and absorbs shock on the bone surface is called cartilage. As we get older or face any kind of traumatic injury, cartilage undergoes wear and tear and affects the loading of joints. Due to several drawbacks of the conventional methods used for the repairing of cartilage it has been replaced by the regenerative therapy which has gained its importance with emerging technology. Cartilage repair/regeneration is a type of regenerative therapy prominently used for the regeneration of damaged cartilage.

Increasing geriatric population has resulted in the increasing number of cartilage distortion problem because of old age, people are highly prone to cartilage damage mainly due to the reduction of lubricants over the course of time. According to the World Health Organization, the number of people of age 60 or above is estimated to be doubled by 2050, rising from 962 million in 2017 to 2.1 billion in 2050 globally. Moreover increasing road accidents under the influence of distorted roads, harsh weather conditions, reckless driving, etc. is furthermore propelling the growth of the cartilage repair/regeneration market. According to the statics published by the World Health Organization in 2016, around 1.25 million people died in road accidents worldwide. However, the high cost of treatment may pose a challenge to the cartilage repair/regeneration market. Nevertheless, growing awareness about advantages of the technology, advanced therapies, and treatment methodologies along with the prominent investment in research and development of cartilage repair/regeneration market across the globe are expected to act as driving factor for the cartilage repair/regeneration market in the near future.

 
The cartilage repair/regeneration market is divided by treatment modality, type, treatment, and end-use. Based on treatment modality, the cartilage repair/regeneration market has been segmented into cell-based and non-cell based. The cell-based segment is sub-segmented into growth factor technology, chondrocyte transplantation, and stem cells. The non-cell segment is sub-segmented into cell-free composites, tissue scaffolds, and stem cells. By treatment modality, cell-based treatment is estimated to hold the largest market value share attributed to the fact of long-term & effective results.

On the basis of treatment, the cartilage repair/regeneration market is segmented into cartilage replacement and cartilage repair. The cartilage replacement segment is sub-segmented into autologous chondrocyte implantation and osteochondral transplant. The cartilage repair segment is sub-segmented into cell-based cartilage resurfacing, microfracture, and non-surgical treatment.

By type segment, cartilage repair/regeneration market is categorized into fibrocartilage, hyaline cartilage, and elastic cartilage.
Based on end use, the cartilage repair/regeneration market is classified into ambulatory surgical centers, surgical centers, hospitals and clinics and others. Hospital & clinics segment hold maximum share and is expected to boost the market over the forecast period.

North America is anticipated to be the dominant region in the cartilage repair/regeneration market over the forecast period. Favorable government policies supporting the invasion of new and advanced therapies, development in the healthcare infrastructure, and research granted by the government and ruling authorities are expected to propel the growth of the market in this region. Europe is the second largest market followed by Asia Pacific. Large healthcare industry due to the large population base in the Asia Pacific region, especially India, China, and Japan is the significant accelerating factor for the growth of the cartilage repair/regeneration market in this region. Therefore, Asia Pacific is anticipated to show the fastest CAGR growth during the forecast period; whereas Latin America market is estimated to grow at a slow to moderate rate during the forecast period. The Middle East and Africa are also expected to cover the prominent market value share in the cartilage repair/regeneration market global market.

Some of the key players in cartilage repair/regeneration market include Osiris Therapeutics, Inc., Smith & Nephew Plc, Vericel Corporation, Depuy Synthes, Zimmer Biomet Holdings, Inc., B. Braun Melsungen AG, Anika Therapeutics S. R. L, Conmed Linvatec, RTI Surgical, Arthrex, Inc., etc.